Article -> Article Details
| Title | Pain Patch Market Demand, Growth, Opportunities, Top Key Players and Forecast to 2027 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Pain Patch Market |
| Owner | Vijay k |
| Description | |
| According to MRFR analysis, Pain Patch Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and is likely to be valued at USD 29.5 Billion by 2025. Pain patches are used to manage pain caused due to neurological diseases, injury, cancer pain, and others. The pain patches are transdermal drug delivery devices that release the active substance or opioid into the skin to reduce the pain. The growth of the Global Pain Patch Market is determined by numerous factors such as an increasing number of patients having joint pain, muscular pain, a growing geriatric population with either one of the disease-causing pains increases the demand for pain patches. Also, the increasing demand for the alternative of oral drug for pain management rises the market growth. However, the side effects associated with the pain patches and lack of awareness about the product are likely to hamper the growth of the global pain patch market during the forecast period. Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/8569 Segmentation The Global Pain Patch Market has been segmented based on type, mode of administration, therapeutic use, and end-users.
Key Players Some of the Key Players in the Global Pain Patch Market are LTS Lohmann Therapie-Systeme AG (Germany), NanoVibronix. (US), Mylan N.V.(US), Pfizer, Inc. (US), Teva Pharmaceutical Company (Allergan Plc (Actavis)) (Israel), Endo Pharmaceuticals Inc (Israel), Hisamitsu America, Inc. (America), Johnson & Johnson (US), Teikoku Seiyaku Co., Ltd. (Japan), Sanofi (France), NICHIBAN Co (Japan), The Mentholatum Company (US), and others. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the increasing number of patient suffering from central nervous system problem, increasing sedentary lifestyle, and growing demand for innovative technology and product as an alternative to medication for pain management drives the market growth during the forecasted period. Get Access Full Report @ https://www.marketresearchfuture.com/reports/pain-patch-market-8569 The European pain patch market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The pain patch market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising geriatric population having a problem in swallowing and the patient sensitive to oral drugs boosts the demand for pain patches in this region. The pain patch market in the Middle East & Africa has been divided into the Middle East and Africa. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America +1 646 845 9312 | |
